FOXP3 and systemic sclerosis: in CD4+ T cells from patients with systemic sclerosis, treatment with all-trans retinoic acid, a natural derivative of vitamin A, increases the expression of FOXP3 and, subsequently the proportion of Treg cells by promoting demethylation of the FOXP3 promoter.